Pharma companies' strategies for reaching poorer countries remain unclear

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 31 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 33%
  • Publisher: 71%

Cancer News

Diabetes,Drugs,Healthcare

Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.

SciDev.NetSep 12 2024 Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.

Iyer says companies first need to know how many treatment-eligible patients there are in each of their markets. “You need to know the burden of a disease, so that you know how many people you’re going to be reaching – and then reach them with your efforts,” she says. Out of 42 patient-reach approaches that the companies spelt out, 13 don’t include any goals. More than a third of the existing goals aren’t clear and measurable, says the report.

But that’s not true of all countries, she says. And from the perspective of local communities, this can feel like companies are not making the effort.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

For pharma, Trump vs. Harris is a showdown between two industry foesFormer President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It's up to the government to cut high U.S. drug prices.
Source: medical_xpress - 🏆 101. / 51 Read more »